<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialRecordOutput xmlns:ns2="local" id="241202"><TitleDisplay>Non-interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations</TitleDisplay><TitleOfficial>Non-interventional Study (NIS): Clinical Investigation for Evaluation of the Safety and Efficacy of Ectoin Ear Spray and Normison Ear Spray in Skin Treatment of Outer Ear Canal Irritations: A Mulitcenter Non-interventional Study</TitleOfficial><OutcomesAvailable>No</OutcomesAvailable><EndpointsAchieved>Unknown</EndpointsAchieved><Identifiers><Identifier type="NCT">NCT02558738</Identifier><Identifier type="Organisational Study">EOS_PPL-084</Identifier></Identifiers><Indications><Indication id="3792">Otitis</Indication></Indications><BiomarkerNames></BiomarkerNames><InterventionsPrimaryByRegimen regimenType="single"><Interventions><Intervention type="InterventionPrimary"><Name>Ectoin ear spray</Name></Intervention></Interventions></InterventionsPrimaryByRegimen><InterventionsControlByRegimens><InterventionsControlByRegimen regimenType="single"><Interventions><Intervention type="InterventionControl"><Name>Normison ear spray</Name></Intervention></Interventions></InterventionsControlByRegimen></InterventionsControlByRegimens><DrugsAsInterventionPrimary></DrugsAsInterventionPrimary><CrossReferences><SourceEntity id="28944" type="Company"><TargetEntity id="5037099504" type="organizationId">biotop GmbH</TargetEntity></SourceEntity><SourceEntity id="3792" type="ciIndication"><TargetEntity id="D010031" type="MeSH"></TargetEntity><TargetEntity id="-1715324959" type="omicsDisease"></TargetEntity><TargetEntity id="896" type="siCondition"></TargetEntity></SourceEntity></CrossReferences><Phase>Phase Not Applicable</Phase><RecruitmentStatus id="4">Completed</RecruitmentStatus><NumberOfSites>3</NumberOfSites><CompaniesSponsor><Company id="28944">Bitop GmbH</Company></CompaniesSponsor><CompaniesCollaborator></CompaniesCollaborator><IsCommerciallySignificant>No</IsCommerciallySignificant><Technologies></Technologies><TermsPatientSelection><Term>Aged Adults (65-79 yrs)</Term><Term>Elderly Adults (80 and over)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Young Adults (18-44 yrs)</Term></TermsPatientSelection><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Prospective</Term><Term>Observational</Term></TermsDesign><PatientCountEnrollment>60</PatientCountEnrollment><DateStart>2015-06-30T00:00:00Z</DateStart><DateEnd type="actual">2015-09-30T00:00:00Z</DateEnd><DateChangeLast>2018-05-11T12:14:58Z</DateChangeLast><DateAdded>2015-09-29T00:00:00Z</DateAdded><Contacts><Contact type="Scientific contact"><Affiliation>HNO Praxis Elmshorn</Affiliation><Name>Uwe Sonnemann, Dr med</Name></Contact></Contacts><CriteriaInclusion>&lt;Inclusion&gt;&lt;ul&gt;&lt;li&gt;According to instructions for use&lt;/li&gt;&lt;/ul&gt;&lt;/Inclusion&gt;</CriteriaInclusion><CriteriaExclusion>&lt;Exclusion&gt;&lt;ul&gt;&lt;li&gt;Otitis media, acute otitis media&lt;/li&gt;&lt;li&gt;Acute otitis externa&lt;/li&gt;&lt;li&gt;Earache&lt;/li&gt;&lt;li&gt;Perforation of the ear-drum (membrana tympani)&lt;/li&gt;&lt;li&gt;Infections at the ear&lt;/li&gt;&lt;li&gt;Systemic corticosteroid treatment or local at the ear&lt;/li&gt;&lt;/ul&gt;&lt;/Exclusion&gt;</CriteriaExclusion><MeasuresOutcome><MeasuresPrimary><Measure><Description>Pruritus at outer ear canal: assessment of the symptoms on visual analogous scale</Description><Timeframe>14 days</Timeframe></Measure></MeasuresPrimary><MeasureSecondary><Measure><Description>Change in number of adverse events: incidence of adverse events and correlation to therapy</Description><Timeframe>14 days</Timeframe></Measure><Measure><Description>Dermatitis: assessment of the symptoms of scaly dermatitis on Visual Analog Score on values between 0 and 10</Description><Timeframe>14 days</Timeframe></Measure><Measure><Description>Efficacy: assessment on Visual Analog Score on values between 0 and 10</Description><Timeframe>14 days</Timeframe></Measure><Measure><Description>Severity of pruritus: assessment of the symptom on Visual Analog Score on values between 0 and 10</Description><Timeframe>14 days</Timeframe></Measure><Measure><Description>Tolerability: assessment on Visual Analog Score on values between 0 and 10</Description><Timeframe>14 days</Timeframe></Measure><Measure><Description>Burning issue on skin: assessment of the symptom on Visual Analog Score on values between 0 and 10</Description><Timeframe>14 days</Timeframe></Measure></MeasureSecondary></MeasuresOutcome><ProtocolAndOutcomes><AimsAndScope>&lt;AimAndScope&gt;&lt;para&gt;In this observational study, insights regarding the tolerability and influence on the      quality of life of the topical treatment with Ectoin Ear Spray compared to Normison ear      spray would be gained under real life conditions in patients with chronic eczematous      irritations and pruritus of the outer ear canal.&lt;/para&gt;&lt;/AimAndScope&gt;</AimsAndScope><ProtocolDescription>&lt;ProtocolDescription&gt;&lt;para&gt;Patients who receive  Ectoin or Normison ear      spray treatment according to instruction for use would be enrolled and observed.&lt;/para&gt;&lt;/ProtocolDescription&gt;</ProtocolDescription></ProtocolAndOutcomes><AdverseEventsByInterventions></AdverseEventsByInterventions><DoseRouteByInterventions></DoseRouteByInterventions><SitesByCountries><SitesByCountry country="Germany"><Sites><Site><Name>HNO Bergmann-Omar</Name><Address1>Norderstedt</Address1><Address3>22846</Address3><Contacts></Contacts></Site><Site><Name>HNO Moeller</Name><Address1>Lueneburg</Address1><Address3>21335</Address3><Contacts></Contacts></Site><Site><Name>HNO Praxis Elmshorn</Name><Address1>Elmshorn</Address1><Contacts></Contacts></Site></Sites></SitesByCountry></SitesByCountries><PatientSegmentTerms></PatientSegmentTerms><TrialRegistries><Registry><Name id="1000">NLM ClinicalTrials.gov</Name><Identifiers><Identifier type="NCT">NCT02558738</Identifier></Identifiers></Registry></TrialRegistries><OutcomeMeasureTerms></OutcomeMeasureTerms><PrimaryCompletionDate type="Actual">2015-08-31T00:00:00Z</PrimaryCompletionDate><DateFirstReceived>2015-09-14T00:00:00Z</DateFirstReceived><FundersType><Type>Company</Type></FundersType><ChangeHistory><Change type="added"><Date>2015-09-29T00:00:00Z</Date><Reason id="301">Clinical trial added</Reason></Change></ChangeHistory></ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialRecordOutput>